title: Glucocorticoid-induced osteoporosis: an update.
abstract: Glucocorticoid-induced osteoporosis occurs in two phases: a rapid, early phase in which bone mineral density is reduced, possibly as a result of excessive bone resorption, and a slower, progressive phase in which bone mineral density declines because of impaired bone formation. Although the indirect effects of glucocorticoids on bone are evident, their direct effects on osteoblasts, osteoclasts and osteocytes are primarily operative in the pathogenesis of glucocorticoid-induced osteoporosis. The management of patients exposed to glucocorticoids includes general health measures, sufficient calcium and vitamin D, and reducing the therapeutic regimen to the minimal effective dose. The gold standard in the pharmacological treatment of glucocorticoid-induced osteoporosis in postmenopausal women involves the use of bisphosphonates, which should be started soon after beginning chronic glucocorticoid therapy. Anabolic and alternative therapeutic strategies are currently under investigation in glucocorticoid-induced osteoporosis.
authors: Department of Internal Medicine, Spedali Civili, University of Brescia, 25125 Brescia, Italy.
authors: Gherardo
authors: G
authors: Mazziotti
authors: Alberto
authors: A
authors: Angeli
authors: John P
authors: JP
authors: Bilezikian
authors: Ernesto
authors: E
authors: Canalis
authors: Andrea
authors: A
authors: Giustina